WST

New York Stock Exchange

West Pharmaceutical Services, Inc. · Healthcare · Life Sciences Tools & Services

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$21.17B

PE Ratio

39.7821

EV to Ebitda

24.0458

Earnings Yield

2.51%

Revenue (TTM)

$3.22B

Net Income (TTM)

$542.7M

Revenue (Annual YoY Growth)

6.29%

Revenue (Quarterly YoY Growth)

20.97%

Profit Margin

16.85%

Return on Equity

18.30%

Debt to Equity Ratio

0.1073

Dividend Yield

0.29%

All fundamentals

Core10 fields›

Market Cap$21.17B

Revenue TTM$3.22B

Shares Outstanding70.6M

Float72804454

Float Short3.89%

Days To Cover2.8622932326

Short Interest2728997.0

Insider Ownership4.05%

Relative Strength63.7

GARP62

Growth Estimates19 fields›

Revenue Growth (Annual)6.29%

Revenue Growth (Quarterly YoY)20.97%

Operating Revenue Growth (Annual)0.094277

Operating Revenue Growth (Quarterly YoY)0.007248

3-Year Revenue Growth2.14%

5-Year Revenue Growth7.45%

EPS Growth (Annual)1.58%

EPS Growth (Quarterly YoY)55.85%

3-Year EPS Growth Rate-4.22%

5-Year EPS Growth Rate8.26%

LT EPS Growth Estimates13.32%

EBITDA Growth (Annual)7.73%

EBITDA Growth (Quarterly YoY)34.44%

CFO Growth (Annual)15.52%

CFO Growth (Quarterly YoY)-30.53%

FCF Growth (Annual)69.65%

FCF Growth (Quarterly YoY)-18.76%

Dividend Growth (Annual)4.88%

Dividend Growth (Quarterly YoY)4.76%

Operations28 fields›

Revenue TTM$3.22B

Gross Margin TTM36.27%

Gross Margin (Quarterly)35.11%

R&D % of Revenue TTM2.29%

R&D Expenses TTM$73.8M

Operating Margin TTM21.40%

Operating Margin (Quarterly)21.45%

Operating Expenses TTM$478.9M

Profit Margin TTM16.85%

Profit Margin (Quarterly)16.43%

Net Income TTM$542.7M

EPS TTM7.4805

EPS (Quarterly)1.9171

EBIT Margin TTM21.40%

EBIT Margin (Quarterly)21.45%

EBITDA Margin TTM26.89%

EBITDA Margin (Quarterly)26.81%

EBITDA TTM$866.0M

CFO % of Revenue TTM24.55%

CFO % of Revenue (Quarterly)10.64%

CFO TTM$715.3M

Cash Margin22.13%

Capex % of Revenue TTM7.99%

Capital Expenditures$257.3M

FCF % of Revenue TTM15.25%

FCF % of Revenue (Quarterly)5.59%

FCF TTM$458.0M

Fundamental Score10

Efficiency6 fields›

ROE18.30%

ROA13.53%

ROIC16.55%

CROCI13.97%

Stock Comp % (Quarterly)0.78%

Stock Comp % TTM0.77%

Valuation21 fields›

P/E (TTM)39.7821

P/E Forward34.5223

P/E Ex-Cash38.7955

P/S Forward6.3111

PEG2.2774

PEG Forward1.2816

P/CFO30.1834

P/FCF47.1401

EV/EBITDA (TTM)24.0458

EV/EBITDA Forward22.5922

EV/Revenues (TTM)6.4648

EV/Revenues Forward6.2509

EV/CFO24.5631

EV/FCF (TTM)45.4664

Price To Book7.0305

Price to Tangible Book10.1444

Earnings Yield2.51%

FCF Yield2.12%

Dividend Yield0.29%

Payout Ratio11.48%

Value Score3

Relative to Industry11 fields›

Relative Gross Margin (Quarterly)0.8123

Relative Profit Margin (Quarterly)3.0235

Relative P/E1.2372

Relative P/S2.1084

Relative P/B2.085

Relative Earnings Yield0.8083

Relative Dividend Yield0.3019

Relative ROE1.605

Relative ROA2.213

Relative ROIC2.1549

Relative Debt to Equity0.207

Liquidity15 fields›

Cash Per Share7.354

Current Ratio2.7104

Cash & ST Assets$521.4M

Total Debt$299.6M

Goodwill & Intangibles$116.2M

Total Assets$4.11B

Total Liabilities$1.12B

Shareholders Equity$2.99B

Debt to Equity0.1073

Debt to Assets7.81%

Interest Expense$2.1M

Times Interest Earned328.2857

CFO to Debt (TTM)2.2841

Debt to EBITDA (TTM)0.3653

Goodwill % of Assets2.83%

Yields5 fields›

Dividend Yield0.29%

Payout Ratio11.48%

Earnings Yield2.51%

Buyback Yield1.32%

Shareholder Yield1.88%

Options Flow8 fields›

Call Volume21

Put Volume990

Put/Call Ratio47.142857142857146

Call $ Volume25479

Put $ Volume783471

Put/Call $ Ratio30.74967620393265

Call OI3047

Put OI5732